Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Fella Health vs Get Thin MD

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.1

Fella Health

Best for men's weight loss
★★★3.6

Starting at $165/mo

CompoundedSemaglutideTirzepatideBuilt for Men
Visit Fella Health
7.9

Get Thin MD

Best for lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available
★★★★4

Starting at $169/mo

CompoundedSemaglutideTirzepatideBrand
Visit Get Thin MD

Side-by-Side Comparison

FeatureFella HealthGet Thin MD
Overall Score7.1/107.9/10
Starting Price$165/mo$169/mo
Editorial Rating3.6 ★ /54 ★ /5
Features8 features7 features
States Available200
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Fella Health

Pros

  • Specialized vertical — program designed for men, particularly 'bigger guys'
  • Free 1:1 health coaching included with the membership
  • 6-month money-back guarantee if the program doesn't work
  • Flat monthly price stays the same as your dose escalates
  • Both compounded semaglutide and tirzepatide available
  • Discloses partner pharmacies (Strive Pharmacy in AZ, Red Rock Home Pharmacy in UT)

Cons

  • Limited to men's health vertical — not available to women
  • Available in only 20 published states (not nationwide)
  • Exact GLP-1 monthly cost not published on the public site — only an 'under $10/day' starting figure
  • Pricing transparency below industry standard for compounded GLP-1 telehealth

Get Thin MD

Pros

  • 3-month compounded semaglutide plan at $169/month is one of the lowest ongoing prices in the compounded GLP-1 category
  • Price-lock positioning: 'Same price, every dose. No hidden fees.' — per the product page
  • Both compounded and brand-name options available in one platform (compounded semaglutide, compounded tirzepatide, plus brand-name Ozempic and Zepbound where medically appropriate)
  • Nationwide availability with async evaluation — no in-person visit required
  • Broader wellness platform that also offers sermorelin, NAD+, HRT, and hair-loss treatments, so patients can consolidate multiple protocols with one provider
  • Proper FDA compounding disclaimer on the product page: "The FDA does not review or approve any compounded medications for safety or effectiveness."

Cons

  • Compounded medications are not FDA-approved as finished products and lack the formal safety/efficacy review of brand-name Ozempic, Wegovy, Zepbound, and Mounjaro
  • Pharmacy partners not publicly named on the site — no independent way to verify 503A/503B compounding source or per-batch testing
  • State-by-state availability claimed as nationwide but no verbatim state list is published — needs intake signup to confirm whether every state is actually served
  • Clinical efficacy headline ("9.6 pounds in 30 days") is based on 645 self-reported patient data points from Jan 2024 – Apr 2025 — self-reported data is lower-quality than a randomized trial
  • Broader wellness funnel (sermorelin + NAD+ + HRT alongside GLP-1s) means some patients may be upsold into off-weight-loss protocols — readers looking specifically for GLP-1 care should know the platform has a wider vertical mix

Our Verdict

Winner: Get Thin MDScore: 7.9/10

Get Thin MD edges out Fella Health with a higher overall score of 7.9/10 and is particularly strong for lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available. Fella Health remains a solid alternative, especially if you're looking for men's weight loss.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.